lifestyle.spaziotribu.net

Author: Larimar Therapeutics

Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update

May 14, 2026
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia

April 30, 2026
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

March 19, 2026